Victrex (LON:VCT)‘s stock had its “hold” rating restated by research analysts at Numis Securities in a research note issued on Monday. They presently have a GBX 2,550 ($35.23) price target on the stock, up from their prior price target of GBX 2,300 ($31.78). Numis Securities’ target price suggests a potential upside of 2.57% from the company’s current price.

A number of other research analysts also recently weighed in on the company. JPMorgan Chase & Co. upped their price target on Victrex from GBX 2,250 ($31.09) to GBX 2,580 ($35.65) and gave the stock a “neutral” rating in a research note on Monday, January 8th. Liberum Capital reaffirmed a “buy” rating and set a GBX 2,440 ($33.71) price target on shares of Victrex in a research note on Tuesday, December 5th. Barclays dropped their price target on Victrex from GBX 2,350 ($32.47) to GBX 2,270 ($31.36) and set an “equal weight” rating on the stock in a research note on Tuesday, November 28th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 2,600 ($35.92) price target on shares of Victrex in a research note on Tuesday, December 5th. Finally, Peel Hunt downgraded Victrex to a “hold” rating and set a GBX 2,300 ($31.78) price target on the stock. in a research note on Tuesday, October 31st. Eight analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Victrex has a consensus rating of “Hold” and a consensus target price of GBX 2,368.80 ($32.73).

Victrex (LON:VCT) opened at GBX 2,486 ($34.35) on Monday. Victrex has a 52 week low of GBX 1,826 ($25.23) and a 52 week high of GBX 2,772 ($38.30). The stock has a market capitalization of $2,140.00 and a PE ratio of 2,143.10.

In other news, insider Martin Court sold 441 shares of the stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of GBX 2,618 ($36.17), for a total value of £11,545.38 ($15,951.06). Over the last three months, insiders bought 14 shares of company stock valued at $36,018.

ILLEGAL ACTIVITY WARNING: This article was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2018/02/14/victrex-vct-receives-hold-rating-from-numis-securities.html.

Victrex Company Profile

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.

Analyst Recommendations for Victrex (LON:VCT)

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.